Tempus AI (NASDAQ:TEM) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Tempus AI (NASDAQ:TEM) from a sell rating to a hold rating in a research note issued to investors on Saturday morning.

Other equities analysts also recently issued research reports about the company. Lake Street Capital downgraded Tempus AI to a “hold” rating in a report on Monday, July 20th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tempus AI in a research report on Wednesday, June 17th. BTIG Research reiterated a “buy” rating and issued a $80.00 price objective on shares of Tempus AI in a research note on Monday, June 1st. HC Wainwright reiterated a “buy” rating on shares of Tempus AI in a research report on Friday. Finally, Freedom Capital raised shares of Tempus AI to a “hold” rating in a research note on Tuesday, June 30th. Nine research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $68.92.

Tempus AI Stock Performance

Shares of Tempus AI stock opened at $42.91 on Friday. The stock has a market cap of $7.71 billion, a PE ratio of -24.95 and a beta of 3.46. The business has a fifty day simple moving average of $51.63 and a 200-day simple moving average of $53.30. The company has a quick ratio of 3.15, a current ratio of 3.31 and a debt-to-equity ratio of 2.96. Tempus AI has a 12 month low of $41.73 and a 12 month high of $104.32.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The business had revenue of $348.12 million for the quarter, compared to the consensus estimate of $345.44 million. Tempus AI had a negative return on equity of 53.83% and a negative net margin of 22.20%.Tempus AI’s revenue for the quarter was up 36.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.24) earnings per share. On average, sell-side analysts anticipate that Tempus AI will post -1.35 EPS for the current fiscal year.

Insider Transactions at Tempus AI

In other news, CAO Ryan M. Bartolucci sold 4,116 shares of Tempus AI stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total value of $181,392.12. Following the transaction, the chief accounting officer owned 74,041 shares of the company’s stock, valued at $3,262,986.87. This trade represents a 5.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO James William Rogers sold 11,529 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $55.00, for a total transaction of $634,095.00. Following the completion of the sale, the chief financial officer owned 114,866 shares of the company’s stock, valued at $6,317,630. The trade was a 9.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 449,793 shares of company stock worth $23,248,231. 24.26% of the stock is currently owned by company insiders.

Institutional Trading of Tempus AI

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Tempus AI by 8.7% during the 4th quarter. Vanguard Group Inc. now owns 10,258,621 shares of the company’s stock worth $605,772,000 after purchasing an additional 817,014 shares during the period. ARK Investment Management LLC grew its position in Tempus AI by 5.3% during the fourth quarter. ARK Investment Management LLC now owns 7,557,583 shares of the company’s stock worth $446,275,000 after buying an additional 381,816 shares in the last quarter. GC Wealth Management RIA LLC acquired a new stake in Tempus AI during the fourth quarter worth about $399,267,000. Sumitomo Mitsui Trust Group Inc. increased its stake in Tempus AI by 23.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,326,313 shares of the company’s stock valued at $195,636,000 after acquiring an additional 821,490 shares during the period. Finally, Amova Asset Management Americas Inc. increased its stake in Tempus AI by 23.4% during the first quarter. Amova Asset Management Americas Inc. now owns 4,326,313 shares of the company’s stock valued at $195,549,000 after acquiring an additional 821,490 shares during the period. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.